Papillary Hidradenoma of Vulva: a Rare Case Presentation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Malignant Hidradenoma: a Report of Two Cases and Review of the Literature
ANTICANCER RESEARCH 26: 2217-2220 (2006) Malignant Hidradenoma: A Report of Two Cases and Review of the Literature I.E. LIAPAKIS1, D.P. KORKOLIS2, A. KOUTSOUMBI3, A. FIDA3, G. KOKKALIS1 and P.P. VASSILOPOULOS2 1Department of Plastic and Reconstructive Surgery, 2First Department of Surgical Oncology and 3Department of Surgical Pathology, Hellenic Anticancer Institute, "Saint Savvas" Hospital, Athens, Greece Abstract. Introduction: Malignant tumors of the sweat glands difficult (1). Clear cell hidradenoma is an extremely rare are very rare. Clear cell hidradenoma is a lesion with tumor with less than 50 cases reported (2, 3). histopathological features resembling those of eccrine poroma The cases of two patients, suffering from aggressive and eccrine spiradenoma. The biological behavior of the tumor dermal lesions invading the abdominal wall and the axillary is aggressive, with local recurrences reported in more than 50% region, are described here. Surgical resection and of the surgically-treated cases. Materials and Methods: Two histopathological examination ascertained the presence of patients are presented, the first with tumor in the right axillary malignant clear cell hidradenoma. In addition to these region, the second with a recurrent tumor of the abdominal cases, a review of the literature is also presented. wall. The first patient underwent wide excision with clear margins and axillary lymph node dissection and the second Case Reports patient underwent wide excision of the primary lesion and bilateral inguinal node dissection due to palpable nodes. Patient 1. Patient 1 was a 68-year-old Caucasian male who had Results: The patients had uneventful postoperative courses. No undergone excision of a rapidly growing, ulcerous lesion of the additional treatment was administered. -
University of Dundee Hidradenoma Masquerading Digital
CORE Metadata, citation and similar papers at core.ac.uk Provided by University of Dundee Online Publications University of Dundee Hidradenoma masquerading digital ganglion cyst Makaram, Navnit; Chaudhry, Iskander H.; Srinivasan, Makaram S. Published in: Annals of Medicine and Surgery DOI: 10.1016/j.amsu.2016.07.017 Publication date: 2016 Document Version Publisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA): Makaram, N., Chaudhry, I. H., & Srinivasan, M. S. (2016). Hidradenoma masquerading digital ganglion cyst: a rare phenomenon. Annals of Medicine and Surgery , 10, 22-26. DOI: 10.1016/j.amsu.2016.07.017 General rights Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain. • You may freely distribute the URL identifying the publication in the public portal. Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 17. Feb. 2017 Annals of Medicine and Surgery 10 (2016) 22e26 Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com Case report Hidradenoma masquerading digital ganglion cyst: A rare phenomenon * Navnit Makaram a, , Iskander H. -
Please Bring Your ~Rotocol, but Do Not Bring Slides Or Microscopes to T He Meeting, CALIFORNIA TUMOR TISSUE REGISTRY
CALIFORNIA TUMOR TISSUE REGISTRY FIFTY- SEVENTH SEMI-ANNUAL SLIDE S~IINAR ON TIJMORS OF THE F~IALE GENITAL TRACT MODERATOR: RlCl!AlUJ C, KEMPSON, M, D, ASSOCIATE PROFESSOR OF PATHOLOGY & CO-DIRECTOR OF SURGICAL PATHOLOGY STANFORD UNIVERSITY MEDICAL CEllTER STANFOliD, CALIFORNIA CHAl~lAN : ALBERT HIRST, M, D, PROFESSOR OF PATHOLOGY LOMA LINDA UNIVERSITY MEDICAL CENTER L~.A LINDA, CALIPORNIA SUNDAY, APRIL 21, 1974 9 : 00 A. M. - 5:30 P,M, REGISTRATION: 7:30 A. M. PASADENA HILTON HOTEL PASADENA, CALIFORNIA Please bring your ~rotocol, but do not bring slides or microscopes to t he meeting, CALIFORNIA TUMOR TISSUE REGISTRY ~lELDON K, BULLOCK, M, D, (EXECUTIVE DIRECTOR) ROGER TERRY, ~1. Ii, (CO-EXECUTIVE DIRECTOR) ~Irs, June Kinsman Mrs. Coral Angus Miss G, Wilma Cline Mrs, Helen Yoshiyama ~fr s. Cheryl Konno Miss Peggy Higgins Mrs. Hataie Nakamura SPONSORS: l~BER PATHOLOGISTS AMERICAN CANCER SOCIETY, CALIFORNIA DIVISION CALIFORNIA MEDICAL ASSOCIATION LAC-USC MEDICAL CENlllR REGIONAL STUDY GRaJPS: LOS ANGELES SAN F~ICISCO CEt;TRAL VALLEY OAKLAND WEST LOS ANGELES SOUTH BAY SANTA EARBARA SAN DIEGO INLAND (SAN BERNARDINO) OHIO SEATTLE ORANGE STOCKTON ARGENTINA SACRJIMENTO ILLINOIS We acknowledge with thanks the voluntary help given by JOHN TRAGERMAN, M. D., PATHOLOGIST, LAC-USC MEDICAL CENlllR VIVIAN GILDENHORN, ASSOCIATE PATHOLOGIST, I~TERCOMMUNITY HOSPITAL ROBERT M. SILTON, M. D,, ASSISTANT PATHOLOGIST, CITY OF HOPE tiEDICAL CENTER JOHN N, O'DON~LL, H. D,, RESIDENT IN PATHOLOGY, LAC-USC MEDICAL CEN!ER JOHN R. CMIG, H. D., RESIDENT IN PATHOLOGY, LAC-USC MEDICAL CENTER CHAPLES GOLDSMITH, M, D. , RESIDENT IN PATHOLOGY, LAC-USC ~IEDICAL CEUTER HAROLD AMSBAUGH, MEDICAL STUDENT, LAC-USC MEDICAL GgNTER N~IE-: E, G. -
Brooke-Spiegler Syndrome – an Underrecognized Cause of Multiple Familial Scalp Tumors: Report of a New Germline Mutation
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Repositório Institucional dos Hospitais da Universidade de Coimbra 67 DOI: http://dx.doi.org/10.3315/jdcr.2015.1208 Brooke-Spiegler Syndrome – an underrecognized cause of multiple familial scalp tumors: report of a new germline mutation André Castro Pinho, Miguel José Pinto Gouveia, Ana Rita Portelinha Gameiro, José Carlos Pereira Silva Cardoso, Maria Margaria Martins Gonçalo Dermatology Department of Centro Hospitalar e Universitário de Coimbra, Portugal. Corresponding author: Abstract André Castro Pinho, MD Background: Brooke-Spiegler syndrome (BSS) is probably an underdiagnosed ge- Dermatology Department nodermatosis that predisposes for the development of cylindromas, spiradeno- mas and trichoepitheliomas mainly of the head and neck. Wide phenotypic varia- Hospitais da Universidade de Coimbra bility regarding the number and type of lesions can be observed within a family. Centro Hospitalar e Universitário Mutations of the CYLD gene are identified in the vast majority of cases and play de Coimbra a key role in BSS pathogenesis. Praceta Mota Pinto, 3000-075 Coimbra, Main observations: Two first degree relatives with numerous erythematous te- Portugal langiectatic nodules of the scalp present for decades, with recurring tendency re- gardless the multiple previous excisions. Histopathological review of the lesions E-mail: [email protected] revealed predominantly "spiradenocylindromas" in the proband and cylindromas in her sister. The suspicion of BSS was confirmed after detection of a new non- sense germline mutation of CYLD (c.1783C>T pGln 595*) in the proband. Conclusions: BSS diagnosis can be challenging and is based on clinical-patholo- gical correlation, positive familial association and identification of CYLD mutations. -
Adnexal Tumors
10/24/2019 What’s a gland like you doing in a place like this? A practical approach to cutaneous adnexal neoplasms Hafeez Diwan, MD, PhD Departments of Pathology & Immunology and Dermatology Baylor College of Medicine 1 Conflict of interest • None 2 Disclosures • I have nothing to disclose 3 1 10/24/2019 Is the adnexal neoplasm glandular? And if so, where is it located? • Hands and Feet: Digital papillary adenocarcinoma 4 5 6 2 10/24/2019 7 8 Digital Papillary Adenocarcinoma • Solitary • Fingers/toes/palms/soles • Recurrence/metastases 9 3 10/24/2019 10 11 12 4 10/24/2019 3 Points about digital papillary adenocarcinoma • 1. Atypia doesn’t matter – if there is no atypia, it doesn’t mean that it isn’t digital papillary adenocarcinoma 13 3 Points about digital papillary adenocarcinoma • 1. Atypia doesn’t matter – if there is no atypia, it doesn’t mean that it isn’t digital papillary adenocarcinoma • 2. How high can the glandular lesion go up the extremity? • Example of one case that occurred on the thigh? (Alomari A, Douglas S, Galan A, Narayan D, Ko C. Atypical Presentation of digital papillary adenocarcinoma (abstract) J Cutan Pathol. 2014;41:221) 14 3 Points about digital papillary adenocarcinoma (cont’d) • 3. What if you don’t see glands • Hidradenoma on hands and feet • Hunt for a gland? If you see a gland, then what? • Probably best to err on the side of caution and say that a digital papillary adenocarcinoma is not ruled out 15 5 10/24/2019 16 17 18 6 10/24/2019 19 20 21 7 10/24/2019 3 Points about digital papillary adenocarcinoma (cont’d) • 3. -
SJMCR-47474-475.Pdf
DOI: 10.21276/sjmcr.2016.4.7.5 Scholars Journal of Medical Case Reports ISSN 2347-6559 (Online) Sch J Med Case Rep 2016; 4(7):474-475 ISSN 2347-9507 (Print) ©Scholars Academic and Scientific Publishers (SAS Publishers) (An International Publisher for Academic and Scientific Resources) Vulval Papillary Hidradenoma Clinically Mimicking a Sebaceous Cyst- A Case Report Swagata Dowerah, Bandita Das Dept. of Pathology, Assam Medical College, Dibrugarh, Assam *Corresponding author Swagata Dowerah Abstract: Hidradenoma papilliferum is a rare benign adnexal tumor with apocrine differentiation seen in anogenital area of women. We present a 25 year old female presenting with an asymptomatic mass in the vulva. On examination, a single round nodule was seen in the vulva , firm and non-tender. A clinical diagnosis of Bartholin’s cyst was made. On gross examination, a brownish mass measuring 1.5 X 1.5 X 1.5cms was seen which was greyish white on cut section. H &E stained sections showed papillary and complex glandular structures lined by columnar cells with eosinophilic cytoplasm. A diagnosis of papillary hidradenoma was made. This case is presented due to its rarity and to emphasise that while evaluating vulval nodules, hidradenoma needs to be considered, as these lesions lack distinctive clinical characteristics. Keywords: hidradenoma, papilliferum, vulva, sebaceous cyst. INTRODUCTION Hidradenoma papilliferum is a rare benign adnexal tumor having apocrine differentiation ,which usually presents as an asymptomatic flesh-colored nodule in the anogenital area of women [1]. It is considered by some to be an analog of intraductal papilloma of the breast [2]. It probably derives from anogenital mammary-like glands, which often are found in or around the hidradenoma[2, 3]. -
SNOMED CT Codes for Gynaecological Neoplasms
SNOMED CT codes for gynaecological neoplasms Authors: Brian Rous1 and Naveena Singh2 1Cambridge University Hospitals NHS Trust and 2Barts Health NHS Trusts Background (summarised from NHS Digital): • SNOMED CT is a structured clinical vocabulary for use in an electronic health record. It forms an integral part of the electronic care record, and serves to represent care information in a clear, consistent, and comprehensive manner. • The move to a single terminology, SNOMED CT, for the direct management of care of an individual, across all care settings in England, is recommended by the National Information Board (NIB), in “Personalised Health and Care 2020: A Framework for Action”. • SNOMED CT is owned, managed and licensed by SNOMED International. NHS Digital is the UK Member's National Release Centre for the creation of, and delegated authority to licence the SNOMED CT Edition and derivatives. • The benefits of using SNOMED CT in electronic care records are that it: • enables sharing of vital information consistently within and across health and care settings • allows comprehensive coverage and greater depth of details and content for all clinical specialities and professionals • includes diagnosis and procedures, symptoms, family history, allergies, assessment tools, observations, devices • supports clinical decision making • facilitates analysis to support clinical audit and research • reduces risk of misinterpretations of the record in different care settings • Implementation plans for England: • SNOMED CT must be implemented across primary care and deployed to GP practices in a phased approach from April 2018. • Secondary care, acute care, mental health, community systems, dentistry and other systems used in direct patient care must use SNOMED CT as the clinical terminology, before 1 April 2020. -
Sebaceous Neoplasia: Diagnosis, Immunohistochemical Studies, Molecular-Genetics and Relationships to Muir-Torre Syndrome Michael T
Sebaceous neoplasia: Diagnosis, immunohistochemical studies, molecular-genetics and relationships to Muir-Torre Syndrome Michael T. Tetzlaff MD, PhD Associate Professor Departments of Pathology and Translational and Molecular Pathology The University of Texas MD Anderson Cancer Center Houston, Texas Executive Officer Translational Research Program The Alliance for Clinical Trials No relevant conflicts of interest to disclose. Advisory board with Seattle Genetics, Myriad Genetics, Novartis and Galderma. Sebaceous neoplasia • Histopathologic features of sebaceous gland proliferations • Sebaceous hyperplasia • Sebaceous adenoma • Sebaceous epithelioma • Sebaceous carcinoma • Sebaceous gland neoplasia and the relationships to DNA mismatch repair • Molecular genetic alterations of sebaceous carcinoma: • Differentially expressed miRNAs • Mutational signature in sebaceous carcinoma Normal sebaceous glands Normal sebaceous gland Sebaceous hyperplasia • Clinically small, flesh colored papules—typically with a central depression or umbilication on the face • Benign overabundance of superficial sebaceous lobules surrounding a centrally dilated follicular structure normal- appearing sebaceous lobules • Sebaceous lobules are increased in number and abut epidermis • Sebocytes predominate over basaloid cells (only 1-2 layers) Sebaceous hyperplasia Not related to defects in mismatch repair The spectrum of sebaceous neoplasia • Sebaceous adenoma • Sebaceous epithelioma/sebaceoma • Sebaceous carcinoma Sebaceous Adenoma • Benign proliferation of sebocytes -
Papillary Hidradenoma: Immunohistochemical J Clin Pathol: First Published As 10.1136/Jcp.52.11.829 on 1 November 1999
J Clin Pathol 1999;52:829–832 829 Papillary hidradenoma: immunohistochemical J Clin Pathol: first published as 10.1136/jcp.52.11.829 on 1 November 1999. Downloaded from analysis of steroid receptor profile with a focus on apocrine diVerentiation Annamaria OYdani, Anna Campanati Abstract sometimes been shown to express oestrogen Aim—To make a quantitative evaluation receptors and progesterone receptors.1–3 How- by image analysis of oestrogen receptors, ever, there have been few reports on the steroid progesterone receptors, and androgen re- receptor profile of papillary hidradenoma, ceptors in papillary hidradenomas and which has unique clinicopathological features anogenital sweat glands. as it develops only in postpuberal and post- Methods—20 papillary hidradenomas and menopausal women and is localised almost the anogenital sweat glands detected in exclusively to vulvar, perineal, and perianal surgical specimens selected from 10 vul- skin.45 Moreover in recent years several vectomies for squamous carcinoma, eight histological studies of the female anogenital haemorrhoidectomies, and one anal region have carefully examined a new variant of polypectomy, all from female patients, cutaneous glands, the so called “anogenital were investigated by the avidin– sweat glands,” which are considered the most streptavidin peroxidase testing system. likely source of papillary hidradenomas.6 Our Results—90% of papillary hidradenomas objective in this immunohistochemical study and almost all the anogenital sweat glands was to make a quantitative evaluation of showed immunoreactivity for oestrogen oestrogen receptors, progesterone receptors, receptor and, more weakly, for progester- and androgen receptors. By focusing attention one receptor, with immunolabelled nu- on the apocrine diVerentiation of papillary epi- clear area ranging from 10% to 90%. -
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation
International Journal of Molecular Sciences Review Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation Iga Płachta 1,2,† , Marcin Kleibert 1,2,† , Anna M. Czarnecka 1,* , Mateusz Spałek 1 , Anna Szumera-Cie´ckiewicz 3,4 and Piotr Rutkowski 1 1 Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland; [email protected] (I.P.); [email protected] (M.K.); [email protected] (M.S.); [email protected] (P.R.) 2 Faculty of Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland 3 Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland; [email protected] 4 Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, 00-791 Warsaw, Poland * Correspondence: [email protected] or [email protected] † Equally contributed to the work. Abstract: Adnexal tumors of the skin are a rare group of benign and malignant neoplasms that exhibit morphological differentiation toward one or more of the adnexal epithelium types present in normal skin. Tumors deriving from apocrine or eccrine glands are highly heterogeneous and represent various histological entities. Macroscopic and dermatoscopic features of these tumors are unspecific; therefore, a specialized pathological examination is required to correctly diagnose patients. Limited Citation: Płachta, I.; Kleibert, M.; treatment guidelines of adnexal tumor cases are available; thus, therapy is still challenging. Patients Czarnecka, A.M.; Spałek, M.; should be referred to high-volume skin cancer centers to receive an appropriate multidisciplinary Szumera-Cie´ckiewicz,A.; Rutkowski, treatment, affecting their outcome. -
Basal Cell Carcinoma, Superficial and Nodular Typeor
11/10/2015 9(109): Basal cell Carcinoma, Review of Slides nodular type Jason Stratton MD Fundamentals of Mohs Pathology Histology: November second, 2015 • Large dermal basaloid nodules • Cleft formation • Central necrosis • Myxoid degeneration • Focal dropout Duplicate 7(107): Basal Cell Carcinoma, superficial and nodular typeor Histology: • Large dermal basaloid nodules • No cleft left formation • Central necrosis • Focal myxoid degeneration • Focal dropout • Superficial component Distribute Not Do 1 11/10/2015 4(104): BCC Nodular and Infiltrative Histology: Clinically: • Large dermal basaloid nodules • Upper back and face most • Cleft formation common • No central necrosis • Poorly defined plaque • Prominent myxoid degeneration • Infiltrative nests without dense Perineural invasion is more fibrosis common Duplicate 6(106): BCC Nodular and Follicular or Histology: • Variable sized dermal nodules • Focal cleft formation • Contain an arborizing pattern without the dispersion or fibrosis of micronodular 2(101): BCC NodulocysticDistribute Not Histology: • Large sized dermal nodules with central myxoid degeneration or necrosis. As a term Nodulocystic includes both Do nodular and Cystic varieties 2 11/10/2015 5(105): BCC Nodulocystic Histology: • Variably sized dermal nodules • Myxoid degeneration with mucin accumulation • Alcian Blue positive at pH 2.5 Duplicate 3(102): BCC, Fibroepitheliomatous type or Histology: • Arborizing networks and cords of basaloid • Variably basaloid with cleft formation Distribute 1(100): BCC, Matrical type Not -
WHO Classification of Tumors of the Central Nervous System
Appendix A: WHO Classification of Tumors of the Central Nervous System WHO Classification 1979 • Ganglioneuroblastoma • Anaplastic [malignant] gangliocytoma and Zülch KJ (1979) Histological typing of tumours ganglioglioma of the central nervous system. 1st ed. World • Neuroblastoma Health Organization, Geneva • Poorly differentiated and embryonal tumours • Glioblastoma Tumours of Neuroepithelial tissue –– Variants: • Astrocytic tumours –– Glioblastoma with sarcomatous compo- • Astrocytoma nent [mixed glioblastoma and sarcoma] –– fibrillary –– Giant cell glioblastoma –– protoplasmic • Medulloblastoma –– gemistocytic –– Variants: • Pilocytic astrocytoma –– desmoplastic medulloblastoma • Subependymal giant cell astrocytoma [ven- –– medullomyoblastoma tricular tumour of tuberous sclerosis] • Medulloepithelioma • Astroblastoma • Primitive polar spongioblastoma • Anaplastic [malignant] astrocytoma • Gliomatosis cerebri • Oligodendroglial tumours • Oligodendroglioma Tumours of nerve sheath cells • Mixed-oligo-astrocytoma • Neurilemmoma [Schwannoma, neurinoma] • Anaplastic [malignant] oligodendroglioma • Anaplastic [malignant] neurilemmoma [schwan- • Ependymal and choroid plexus tumours noma, neurinoma] • Ependymoma • Neurofibroma –– Myxopapillary • Anaplastic [malignant]neurofibroma [neurofi- –– Papillary brosarcoma, neurogenic sarcoma] –– Subependymoma • Anaplastic [malignant] ependymoma Tumours of meningeal and related tissues • Choroid plexus papilloma • Meningioma • Anaplastic [malignant] choroid plexus papil- –– meningotheliomatous [endotheliomatous,